Dexcom develops and commercializes continuous glucose monitoring (CGM) technology for real-time glucose sensing and diabetes management. Founded in 1999, the company works across biosensor technology, wearable health devices, connected health and health data, with technical work spanning real-time glucose sensing, direct-to-watch connectivity, and the personalised actionable insights derived from continuous physiological data. Its CGM systems provide real-time glucose readings and trends in place of finger-prick snapshot measurements; the first CGM system launched in 2006.
The company's technology is deployed at scale. Dexcom reports having helped eliminate more than 11 billion finger pricks worldwide, with millions of people using its CGM systems and a presence across 52 countries. It employs over 8,000 people. Recent product development includes direct-to-watch glucose monitoring functionality, extending glucose data delivery to wearable platforms.
Dexcom operates in the diabetes care, medical devices, healthcare technology and personal health monitoring sectors. The company states core values of listening, serving with integrity, thinking big and being dependable, with a mission-focused emphasis on empowering people to take control of their overall health through personalised, actionable insights. It maintains an engaged Dexcom Warrior user community of over 20,000 worldwide.
